MSLN and ovarian cancer: Mesothelin (MSLN)-directed CAR-NK92 cells demonstrated effective elimination of MSLN-expressing cell lines (OVCAR-3 and SKOV3), and of subcutaneous and intraperitoneal ovarian cancer in mice models.